Former Defense Secretary Jim Mattis testified on Wednesday in the fraud trial of entrepreneur Elizabeth Holmes, saying that he had been given a false impression about the capability of the blood testing product put forward by her now-defunct company Theranos. The testimony from Mattis, who sat on the board of the company for three years, is a central part of the prosecution’s case characterizing the fallen Silicon Valley star as a savvy operator who misled investors. Regardless of the trial’s… Source link
Read More »23andMe shares rise 21% on first day of trading on Nasdaq
Shares of 23andMe (ME) rose 21% to close at $13.32 apiece in their trading debut on the Nasdaq as the consumer genetic testing company became one of the latest companies to go public via SPAC deal. The public debut comes after 23andMe and the special purpose acquisition company (SPAC) VG Acquisition Corp. announced a merger in February. The deal valued 23andMe’s outstanding shares of capital stock at $3.5 billion. The vast majority of shareholders of VG Acquisition Corp., which was founded… Source link
Read More »Why Sir Richard Branson gave 23andMe millions of dollars to go public – Yahoo Finance
TipRanks 2 “Strong Buy” Penny Stocks With Over 200% Upside on the Horizon Let’s talk about risk and the big picture. It’s an appropriate time, as the big risk – presented by the COVID-19 pandemic – is finally receding thanks to the ongoing vaccination program. COVID is leaving behind an economy that was forced into shutdown one year ago while in the midst of a great expansion, boosted by the deregulation policies. While the new Biden Administration is busy reversing many Trump… Source link
Read More »